In the Brief Report titled “Assessment of Gender-Specific COVID-19 Case Fatality Risk per Malignant Neoplasm Type,” published online April 27, 2023, and in the August 2023 issue of JAMA Oncology, there was an error in the first sentence of the article. The beginning of the COVID-19 pandemic was in mid-March 2020, not mid-March 2019. This article was corrected online.
Reference
- 1.Matsuo K, Mandelbaum RS, Vallejo A, Klar M, Roman LD, Wright JD. Assessment of gender-specific COVID-19 case fatality risk per malignant neoplasm type. JAMA Oncol. 2023;9(8):1113-1118. doi: 10.1001/jamaoncol.2023.0768 [DOI] [PMC free article] [PubMed] [Google Scholar]
